Arni Medica Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.50 Cr
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Revenue Growth 138.60%
- Profit Growth 203.53%
- Ebitda 276.59%
- Net Worth 35.17%
- Total Assets 28.60%
About Arni Medica
Arni Medica Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 December 2019 (Five years and one month 7 days old ). Its registered office is in Sangareddy, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Gangabhavani Parvathaneni, Garikapati Kiran, and Prathipati Vishnumanasa serve as directors at the Company.
Company Details
- Location
Sangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33309TG2019PTC137891
- Company No.
137891
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Arni Medica?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gangabhavani Parvathaneni  | Director | 24-Dec-2019 | Current |
| Garikapati Kiran | Director | 24-Dec-2019 | Current |
| Prathipati Vishnumanasa | Director | 24-Jun-2020 | Current |
Financial Performance of Arni Medica.
Arni Medica Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 138.6% increase. The company also saw a substantial improvement in profitability, with a 203.53% increase in profit. The company's net worth Soared by an impressive increase of 35.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arni Medica?
In 2023, Arni Medica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2021 | Canara Bank | ₹2.00 Cr | Open |
How Many Employees Work at Arni Medica?
Arni Medica has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arni Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arni Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
